RenovoRx, Inc.
RNXT
$0.86
-$0.03-2.89%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -45.50% | -2.19% | -17.85% | -21.18% | -124.91% |
| Total Depreciation and Amortization | 0.00% | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 259.49% | -133.56% | 795.45% | 370.83% | 70.82% |
| Change in Net Operating Assets | 9.01% | 183.10% | 74.90% | -134.55% | -264.02% |
| Cash from Operations | -9.70% | -24.28% | -3.46% | -0.22% | -53.40% |
| Capital Expenditure | -- | 100.00% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 100.00% | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -17.42% | -100.00% | 8,560.00% | -99.65% | 123.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 26.64% | 100.00% | -- | -- | -- |
| Cash from Financing | -16.32% | -100.00% | -100.00% | -99.65% | 99.46% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.14% | -25.36% | -4.18% | -130.84% | 130.97% |